WEST CHESTER, Ohio, Dec. 14 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that it and certain
of its officers have been named as defendants in purported securities class
action lawsuits filed in the United States District Court for the Southern
District of New York. The suits allege violations of the federal securities
laws and seek damages on behalf of pur...
WEST CHESTER, Ohio, Dec. 4 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that David Jay
Drachman, President and Chief Executive Officer, is scheduled to present at
the BMO Capital Markets Focus on Healthcare Conference at the Mandarin
Oriental in New York City on Thursday, December 7th, at 8:45 a.m. ET.
A live Web cast and recording of the presentation w...
WEST CHESTER, Ohio, Nov 28, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today the resignation of
Gene R. McGrevin from the Company's Board of Directors, effective December 1,
2006. Mr. McGrevin has recently been appointed Chairman of the Board at a
privately held medical device company that plans to file for an initial public
offering o...
WEST CHESTER, Ohio, Nov. 22 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that David Jay
Drachman, President and Chief Executive Officer, is scheduled to present at
the 18th Annual Piper Jaffray Healthcare Conference at the Pierre Hotel in New
York City on Wednesday, November 29th, at 12:30 p.m. ET.
A live Web cast and recording of the presentation will ...
Third Quarter Highlights
Revenue of $9.4 million, 31% year-over-year increase, exceeds high end
of guidance
Domestic MIS sales reach a record level of $2.8 million, with
year-over-year growth of 95%
International sales increased 76% year-over-year
Lowered full year 2006 loss per share guidance
Received European approval to market the Isolator(TM) bipolar ablation
system for the treatment of cardiac arrhythmias, including ...
WEST CHESTER, Ohio, Oct. 27 /PRNewswire-FirstCall/-- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that management is
scheduled to present at the C.E. Unterberg, Towbin Life Sciences Conference at
the Palace Hotel in New York on Monday, October 30, at 1:30 p.m. ET.
A live Web cast and recording of the presentation will be available on the
Investor Relations page of AtriCure's Web...
WEST CHESTER, Ohio, Oct. 19 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, will release its financial results
for the quarter ended September 30, 2006 on Wednesday, November 8, 2006 after
the close of the U.S. financial markets.
AtriCure will also host a Web cast and conference call at 5:00 p.m. ET on
Wednesday, November 8, 2006 to discuss third quarter 2006 results. A ...
WEST CHESTER, Ohio, Sept. 25 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that management is
scheduled to present at the UBS Global Life Sciences Conference at Grand Hyatt
New York in New York, NY on Thursday, September 28, 2006 at 8:00 a.m. ET.
A live Web cast and recording of the presentation will be available on the
Investor Relations page of AtriCur...
WEST CHESTER, Ohio, Sept. 18 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that management is
scheduled to present at the A.G. Edwards Emerging Growth Conference 2006 at
The New York Palace Hotel in New York, NY on Wednesday, September 20, 2006 at
3:30 p.m. ET.
A live Web cast and recording of the presentation will be available on the
Investor Relations...
Products to be launched at EACTS/ESTS Joint Meeting in Stockholm
WEST CHESTER, Ohio, Sept. 10 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that it has received
CE Mark approval to market the Isolator Transpolar System for the treatment of
cardiac arrhythmias, including atrial fibrillation (AF). The AtriCure(R)
clamps are the only bipolar radiofrequen...
WEST CHESTER, Ohio, Sept. 7 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that management is
scheduled to present at the Think Equity Partners 4th Annual Growth Conference
at The Ritz-Carlton Hotel in San Francisco, CA on Monday, September 11, 2006
at 11:30 a.m. PT.
A live Web cast and recording of the presentation will be available on the
Investor Rela...
WEST CHESTER, Ohio, Sept. 6 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that management is
scheduled to present at the Thomas Weisel Partners Healthcare Conference 2006
at The Four Seasons Hotel in Boston, MA on Thursday, September 7, 2006 at 9:45
a.m. ET.
A live Web cast and recording of the presentation will be available on the
Investor Relations pa...
Recent Highlights:
Generated second quarter 2006 revenues of $9.6 million, up 11.7%
sequentially
Physicians performed MIS procedures in 65 domestic medical centers
during the quarter
Launched Multifunctional Isolator(TM) Transpolar(TM) Pen System
Launched new Isolator(TM) Transpolar(TM) open clamp
Completed treatment phase of RESTORE-SR II feasibility study
WEST CHESTER, Ohio, Aug. 8 /PRNewswire-FirstCall/ -- AtriCure, Inc....
WEST CHESTER, Ohio, July 24 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that Thomas J.
Etergino resigned as the Company's Vice President and Chief Financial Officer.
The Company expects Mr. Etergino to stay through August 18, 2006, at which
point he will leave to pursue other endeavors. Until Mr. Etergino's successor
is named, David J. Drachman, President...
WEST CHESTER, Ohio, July 20 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, will release its financial results
for the quarter ended June 30, 2006 on Tuesday, August 8, 2006 after the close
of the U.S. financial markets.
AtriCure will also host a Web cast and conference call at 8:30 am ET on
Wednesday, August 9, 2006 to discuss second quarter 2006 results. A live Web
ca...
WEST CHESTER, Ohio, July 20 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today that it has received
Food and Drug Administration (FDA) 510(k) clearance for its Isolator
Transpolar Pen System (Pen) for pacing, sensing, stimulating, and recording
during the evaluation of cardiac arrhythmias in addition to its currently FDA-
cleared use for the ablation of cardiac t...
- Provides 2006 Financial Guidance -
WEST CHESTER, Ohio, May 4 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today financial results for
the first quarter ended March 31, 2006.
First quarter 2006 consolidated revenue was $8.6 million, compared to $7.5
million for the first quarter 2005 and $8.6 million for the fourth quarter
2005. First...
WEST CHESTER, Ohio, April 25 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, will release its financial results
for the quarter ended March 31, 2006 on Thursday, May 4, 2006 after the close
of the U.S. financial markets.
AtriCure will also host a Web cast and conference call at 5:30 pm ET on
Thursday, May 4, 2006 to discuss first quarter 2006 results. A live Web cast
of...
WEST CHESTER, Ohio, April 12 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today the appointment of
Gene R. McGrevin to the Company's Board of Directors. Mr. McGrevin will serve
on AtriCure's Compensation Committee. The appointment brings AtriCure's Board
to 10 members, eight of whom are independent.
Mr. McGrevin, 63, has over 30 years of senior management e...
Fourth Quarter 2005 Highlights
Total revenue increased 49.4% to $8.6 million
Gross margin increased 230 basis points to 75.0%
Performed first human cases in the U.S. using the Isolator(TM)
Endoscopic Ablation System
Enrolled 17 of necessary 25 patients in Restore II clinical trial
Full Year 2005 Highlights
Total revenue increased 61.6% to $31.0 million
First full-year worldwide MIS product revenue of $6.4 million
L...
WEST CHESTER, Ohio, Feb. 13 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, announced today the appointment of
Mark R. Lanning to the Company's Board of Directors. Mr. Lanning will serve
on AtriCure's Audit Committee. The appointment brings AtriCure's Board to
nine members, seven of whom are independent.
Mr. Lanning, 51, currently serves as Vice President and Treasurer ...
WEST CHESTER, Ohio, Feb. 3 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company focused on developing, manufacturing
and selling innovative surgical devices, will release its financial results
for the quarter and year ended December 31, 2005 on Thursday, February 16,
2006 after the close of the U.S. financial markets.
AtriCure will also host a Web cast and conference call at 9:00 am ET on
February 17, 2006 to discuss fourth quarter 2005 results. A live...
